Autophagy and the hallmarks of aging
Autophagy, an essential cellular process that mediates degradation of proteins and
organelles in lysosomes, has been tightly linked to cellular quality control for its role as part …
organelles in lysosomes, has been tightly linked to cellular quality control for its role as part …
The ménage à trois of autophagy, lipid droplets and liver disease
Y Filali-Mouncef, C Hunter, F Roccio, S Zagkou… - Autophagy, 2022 - Taylor & Francis
Autophagic pathways cross with lipid homeostasis and thus provide energy and essential
building blocks that are indispensable for liver functions. Energy deficiencies are …
building blocks that are indispensable for liver functions. Energy deficiencies are …
Metabolic messengers: FGF21
KH Flippo, MJ Potthoff - Nature metabolism, 2021 - nature.com
As a non-canonical fibroblast growth factor, fibroblast growth factor 21 (FGF21) functions as
an endocrine hormone that signals to distinct targets throughout the body. Interest in …
an endocrine hormone that signals to distinct targets throughout the body. Interest in …
FGF21: an emerging therapeutic target for non-alcoholic steatohepatitis and related metabolic diseases
EJ Tillman, T Rolph - Frontiers in endocrinology, 2020 - frontiersin.org
The rising global prevalence of obesity, metabolic syndrome, and type 2 diabetes has driven
a sharp increase in non-alcoholic fatty liver disease (NAFLD), characterized by excessive fat …
a sharp increase in non-alcoholic fatty liver disease (NAFLD), characterized by excessive fat …
Acetyl-CoA metabolism and histone acetylation in the regulation of aging and lifespan
PC Bradshaw - Antioxidants, 2021 - mdpi.com
Acetyl-CoA is a metabolite at the crossroads of central metabolism and the substrate of
histone acetyltransferases regulating gene expression. In many tissues fasting or lifespan …
histone acetyltransferases regulating gene expression. In many tissues fasting or lifespan …
Histones: The critical players in innate immunity
X Li, Y Ye, K Peng, Z Zeng, L Chen, Y Zeng - Frontiers in immunology, 2022 - frontiersin.org
The highly conserved histones in different species seem to represent a very ancient and
universal innate host defense system against microorganisms in the biological world …
universal innate host defense system against microorganisms in the biological world …
Fibroblast growth factor 21 (FGF21) alleviates senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the SIRT1-mTOR signaling pathway
H Lu, C Jia, D Wu, H Jin, Z Lin, J Pan, X Li… - Cell Death & …, 2021 - nature.com
Osteoarthritis (OA) is a complex condition that involves both apoptosis and senescence and
currently cannot be cured. Fibroblast growth factor 21 (FGF21), known for its role as a potent …
currently cannot be cured. Fibroblast growth factor 21 (FGF21), known for its role as a potent …
METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease
Z Peng, Y Gong, X Wang, W He, L Wu, L Zhang… - Molecular Therapy, 2022 - cell.com
N6-methyladenosine (m 6 A) mRNA modification plays critical roles in various biological
events and is involved in multiple complex diseases. However, the role of m 6 A modification …
events and is involved in multiple complex diseases. However, the role of m 6 A modification …
Hepatic transcriptional responses to fasting and feeding
L Bideyan, R Nagari, P Tontonoz - Genes & development, 2021 - genesdev.cshlp.org
Mammals undergo regular cycles of fasting and feeding that engage dynamic transcriptional
responses in metabolic tissues. Here we review advances in our understanding of the gene …
responses in metabolic tissues. Here we review advances in our understanding of the gene …
AKR-001, an Fc-FGF21 analog, showed sustained pharmacodynamic effects on insulin sensitivity and lipid metabolism in type 2 diabetes patients
A Kaufman, L Abuqayyas, WS Denney, EJ Tillman… - Cell Reports …, 2020 - cell.com
Experimental fibroblast growth factor 21 (FGF21) analogs can improve lipid profiles in
patients with metabolic diseases. However, their effects on markers of insulin sensitivity …
patients with metabolic diseases. However, their effects on markers of insulin sensitivity …